How Cost-Effective Is Zika Virus Screening? In 2016, the United States began mandated screening of individual donations for the Zika Virus (ZIKV) using nucleic acid testing… October 31, 2018
Eculizumab for Treating Cold Agglutinin Disease Cold agglutinin disease (CAD) is a rare autoimmune disease caused by antibodies directed against red blood cell antigens, making them… October 24, 2018
Sexually Transmitted Disease Rates among Reinstated MSM Donors In December 2016, the American Red Cross began collecting blood from men who have sex with men (MSM) in… October 17, 2018
Increased Risk of Myocardial Ischemia and Death in Severely Anemic Patients who Decline Transfusions Increased cardiac output can aid oxygen delivery in patients with mild anemia. When a critical hemoglobin (Hb) concentration is reached… October 10, 2018
Blood Collection and Processing Methods Affect Inflammatory Response in Vitro Numerous studies have examined whether storage time affects the safety and quality of red blood cells (RBCs), but few studies… October 3, 2018
Cryopreserved Platelets Are Safe and Prevent Bleeding Cryopreservation of platelets could drastically simplify storage of platelets, especially for difficult locations such as combat zones, trauma centers, and… September 26, 2018
Matching RH Genotypes for Patients with Sickle Cell Disease RH antigens are encoded by two highly polymorphic genes, RHD and RHCE. Homologous recombination and novel polymorphism have resulted in… September 19, 2018
Red Cell Exchange for Patients with Sickle Cell Disease: an AABB Report The Therapeutic Apheresis Subsection of the AABB, composed of 15 practicing apheresis physicians from 14 institutions, recently summarized how they… September 12, 2018
Reducing the risk of transfusion transmitted Babesia: an AABB Report Babesia is an intraerythorcytic parasite transmitted by black-legged ticks and is also the most common infectious agent for transfusion transmitted… September 12, 2018
Emicizumab Therapy for Hemophilia A Treatment for hemophilia A usually involves intravenous injections of factor VIII multiple times a week. In 2012, emicizumab (a bispecific… September 5, 2018
